Yale 3rd Yale International Rheumatology State-of-the-Art Symposium Do No Harm Risk Mitigation in Rheumatic Disease Patients 2023

Yale 3rd Yale International Rheumatology State-of-the-Art Symposium Do No Harm Risk Mitigation in Rheumatic Disease Patients 2023

Format: 3 videos + 13 pdfs, size: 7.05 GB

Course Audience: rheumatologist

Overview:

Friday, April 28, 2023, 11:30 AM – Saturday, April 29, 2023, 1:30 PM, Maurice R. Greenberg Conference Center, New Haven, CT

Target Audience

Specialties – Rheumatology

Overview

DATE	TIME
April 28, 2023	12:00 PM—4:40 PM EST
April 29, 2023	7:00 AM—1:30 PM EST

Over the past 20 years, rheumatology has witnessed tremendous therapeutic advances. Progress in treatment with traditional small molecules and the rise of biologic therapy offers improved outcomes for rheumatic disease patients. With advances in efficacy comes increasing therapeutic complexity and the need to avoid harm.

In this two-day Yale Symposium, we will bring together a faculty of internationally recognized experts to discuss risk mitigation for rheumatic disease patients. We will also consider the needs of special populations such as underserved, pregnant, and peri-operative patients and the role of vaccination.

PLANNERS

COURSE DIRECTOR

Robert Schoen MD, MBA Clinical Professor of Rheumatology Yale School of Medicine

CO-DIRECTORS

Richard Bucala MD, PhD Chief, Rheumatology, Allergy & Immunology Waldemar Von Zedtwitz  Professor of Medicine, Pathology, and Epidemiology & Public Health Yale University Rheumatologist-in-Chief Yale New Haven Health

Vaidehi Chowdhary, MBBS, MD, DM Associate Professor Clinical Chief, Rheumatology, Allergy, & Immunology Yale School of Medicine

Objectives

1. Better recognize and mitigate risk in rheumatic disease patients.
2. Discuss the role of vaccination in rheumatic disease patients.
3. Review the needs of special rheumatic disease populations, including underserved, pregnant, and peri-operative patients

 

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

April 28 (Video MP4 Format)

April 29 Part 1 (Video MP4 Format)

April 29 Part 2 (Video MP4 Format)

Assessment of Infection Risk in Rheumatic Disease Patients Treated with Biologic Therapy (PDF Format)

Benefit and Risk in the Treatment of Gout (PDF Format)

Checkpoint Inhibitors- Musculoskeletal Manifestations and Treatment (PDF Format)

Genetic and Socioeconomic Risk Disparities in Rheumatic Disease Treatment. (PDF Format)

Hydroxychloroquine Toxicity (PDF Format)

Management of Rheumatic Disease in Pregnancy (PDF Format)

Methotrexate Risk in Rheumatology (PDF Format)

Mitigating Glucocorticoid Toxicity (PDF Format)

Perioperative Management of Immunosuppression in Patients with Rheumatoid Arthritis (PDF Format)

Rheumatology Symposium 2023_Agenda and Program Overview__v4_NVP_FINAL (PDF Format)

Safety of Jak Inhibitors (PDF Format)

The Clinical Manifestations, Prevention, and Treatment of COVID Infection in Rheumatology Patients (PDF Format)

Vaccines and Biologics (PDF Format)

 

*Detail:

Friday, April 28, 2023

11:30AM – 12:15PM Registration and Exhibits

12:15PM – 12:30PMWelcome and Introductions Richard Bucala, MD, PhD

12:30PM – 2:00PM Session I: Infections in Rheumatology-Vaccines and COVID Robert Schoen, MD, MBA (Moderator)

12:30PM – 12:55PM Preventive Immunizations in Rheumatic Disease Patients Camille N. Kotton, MD (Speaker)

12:55PM – 1:20PM Vaccines and Biologics Barbara E. Ostrov, MD (Speaker)

1:20PM – 1:45PM The Clinical Manifestations, Prevention, and Treatment of COVID Infection in Rheumatology Patients Marwan Azar, MD (Speaker)

1:45PM – 2:00PM Panel Q&A

2:00PM – 2:20PM Refreshment Break and Exhibits

2:20PM – 4:25PM Session II: Biological Therapies and Jak Inhibitors Vaidehi Chowdhary, MBBS, MD, DM (Moderator)

2:20PM – 2:45PM Does Biologic Therapy Increase the Risk of Lymphoma and Other Malignancies in Rheumatoid Arthritis? Gerd R Burmester, MD, Professor (Speaker)

2:45PM – 3:10PM Assessment of Infection Risk in Rheumatic Disease Patients Treated with Biologic Therapy Jasvinder A Singh, MD (Speaker)

3:10PM – 3:35PM Safety of Jak Inhibitors Stanley Cohen, MD (Speaker)

3:35PM – 4:00PM Perioperative Management of Immunosuppression in Patients with Rheumatoid Arthritis Susan M Goodman, MD (Speaker)

4:00PM – 4:25PM Checkpoint Inhibitors: Musculoskeletal Manifestations and Treatment Ami Shah, MD, MHS (Speaker)

4:25PM – 4:45PM Panel Q&A

5:30PM – 8:30PM DINNER AND MUSIC Presented by THE HAVENWOOD QUARTET

Saturday, April 29, 2023

7:30AM – 8:00AM Registration and Exhibits

8:00AM – 8:10AM Welcome Back Robert Schoen, MD, MBA

8:10AM – 9:25AM Session III: Risk Assessment and Special Populations Richard Bucala, MD, PhD (Moderator)

8:10AM – 8:35AM Strategies for Risk Assessment, Outcomes Measurement, and the Quality of Evidence. Jeffrey R. Curtis, MD, MS, MPH (Speaker)

8:35AM – 9:00AM Genetic and Socioeconomic Risk Disparities in Rheumatic Disease Treatment. Lisa Suter, MD (Speaker)

9:00AM – 9:25AM Management of Rheumatic Disease in Pregnancy Lisa R. Sammaritano, MD (Speaker)

9:25AM – 9:50AM Panel Q&A

9:50AM – 10:10AM Refreshment Break and Exhibits

10:10AM – 12:40PM Session IV: Small Molecule Therapies, Cardiovascular Risk and Glucocorticoid Therapy Vaidehi Chowdhary, MBBS, MD, DM (Moderator)

10:10AM – 10:35AM Risk in the Treatment of Osteoarthritis David Felson, MD, MPH (Speaker)

10:35AM – 11:00AM Hydroxychloroquine Toxicity William J McCune, MD (Speaker)

11:00AM – 11:25AM Methotrexate Risk in Rheumatology Daniel H. Solomon, MD, MPH (Speaker)

11:25AM – 11:50AM Mitigating Cardiovascular Risk in Rheumatic Diseases Michael S Garshick, MD (Speaker)

11:50AM – 12:15PM Mitigating Glucocorticoid Toxicity Julia Charles, MD, PhD (Speaker)

12:15PM – 12:40PM Benefit and Risk in the Treatment of Gout Michael H. Pillinger, MD (Speaker)

12:40PM – 1:00PM Panel Q&A

1:00PM – 1:25PM Closing Remarks Robert Schoen, MD, MBA